ReviewThorax1995
Oxidants/antioxidants in idiopathic pulmonary fibrosis.
Review in Thorax, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it, 91 citations in OpenAlex.
- Non-steroid agents for idiopathic pulmonary fibrosis.The Cochrane database of systematic reviews · 2010Pooled it
- HIP/PAP protects against bleomycin-induced lung injury and inflammation and subsequent fibrosis in mice.Journal of cellular and molecular medicine · 2020Article
- Lung extracellular matrix and redox regulation.Redox biology · 2016Review
- Oxidative Modifications of Protein Tyrosyl Residues Are Increased in Plasma of Human Subjects with Interstitial Lung Disease.American journal of respiratory and critical care medicine · 2016Article
- Lipidomics revealed idiopathic pulmonary fibrosis-induced hepatic lipid disorders corrected with treatment of baicalin in a murine model.The AAPS journal · 2015Article
- Preventive effect of chrysin on bleomycin-induced lung fibrosis in rats.Inflammation · 2014Article
- Novel therapeutic approaches for pulmonary fibrosis.British journal of pharmacology · 2011Review
- Oxidative stress, extracellular matrix targets, and idiopathic pulmonary fibrosis.Free radical biology & medicine · 2010Review
- Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis.Antioxidants & redox signaling · 2008Review
- Extracellular superoxide dismutase in pulmonary fibrosis.Antioxidants & redox signaling · 2008Review
- Long-term administration of a small molecular weight catalytic metalloporphyrin antioxidant, AEOL 10150, protects lungs from radiation-induced injury.International journal of radiation oncology, biology, physics · 2007Article
- The oxidant-antioxidant balance in systemic sclerosis cases with interstitial lung involvement.Rheumatology international · 2006Article
- Overexpression of extracellular superoxide dismutase reduces acute radiation induced lung toxicity.BMC cancer · 2005Article
- Article
- Review
- In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats.British journal of pharmacology · 2003Article
- Review
- Analysis of carbonylated proteins in bronchoalveolar lavage of patients with diffuse lung diseases.LungArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.